|
| Exchange Received Time 04/09/2018 11:13:10 Exchange Disseminated Time 04/09/2018 11:13:18 Time Taken 00:00:08 | Dear Sir,
We have been informed on September 3, 2018 that the Competition Commission of India has passed an order under Section 31(1) of the Competition Act, 2002 (Act) dated 24 July 2018 in a notice filed by Procter & Gamble Overseas India B.V. under Section 6(2) of the Act, approving the transaction involving inter alia the proposed acquisition by Procter & Gamble Overseas India B.V. of 51.8% of the equity share capital of the Company and the proposed transfer of the non-consumer health business of the Company to Merck Life Science Pvt. Ltd. or any of its affiliates on a going concern basis by way of slump sale. We are making this announcement pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This is for your information and record.
Thanking you,
Yours faithfully
For Merck Limited
Vikas R. Gupta
General Counsel & Company Secretary
|
|
|